Evasion of host immune defenses by human papillomavirus

•HPV dysregulates various molecular and cellular pathways to evade host defenses.•HPV alters transcription of key immune modulators.•HPV E6 and E7 interacts with core proteins of the interferon pathway.•HPV E5 and E7 downregulate surface expression of MHC molecules.•Papillomavirus genome evolution m...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Virus research 2017-03, Vol.231, p.21-33
Hauptverfasser: Westrich, Joseph A., Warren, Cody J., Pyeon, Dohun
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 33
container_issue
container_start_page 21
container_title Virus research
container_volume 231
creator Westrich, Joseph A.
Warren, Cody J.
Pyeon, Dohun
description •HPV dysregulates various molecular and cellular pathways to evade host defenses.•HPV alters transcription of key immune modulators.•HPV E6 and E7 interacts with core proteins of the interferon pathway.•HPV E5 and E7 downregulate surface expression of MHC molecules.•Papillomavirus genome evolution may be driven by virus evasion of host restriction. A majority of human papillomavirus (HPV) infections are asymptomatic and self-resolving in the absence of medical interventions. Various innate and adaptive immune responses, as well as physical barriers, have been implicated in controlling early HPV infections. However, if HPV overcomes these host immune defenses and establishes persistence in basal keratinocytes, it becomes very difficult for the host to eliminate the infection. The HPV oncoproteins E5, E6, and E7 are important in regulating host immune responses. These oncoproteins dysregulate gene expression, protein–protein interactions, posttranslational modifications, and cellular trafficking of critical host immune modulators. In addition to the HPV oncoproteins, sequence variation and dinucleotide depletion in papillomavirus genomes has been suggested as an alternative strategy for evasion of host immune defenses. Since anti-HPV host immune responses are also considered to be important for antitumor immunity, immune dysregulation by HPV during virus persistence may contribute to immune suppression essential for HPV-associated cancer progression. Here, we discuss cellular pathways dysregulated by HPV that allow the virus to evade various host immune defenses.
doi_str_mv 10.1016/j.virusres.2016.11.023
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5325784</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0168170216305627</els_id><sourcerecordid>1844353816</sourcerecordid><originalsourceid>FETCH-LOGICAL-c504t-f1ad49afb2c0d0df0e26c842a2216ea5deef4ecb0348a7008a93252271fb53f73</originalsourceid><addsrcrecordid>eNqFkU1PwzAMhiMEgjH4C6hHLi35apNeEAiNDwmJC5yjNHVYprYZSTuJf09gDMGJk2P59WvHD0JnBBcEk-piVWxcmGKAWNCUF4QUmLI9NCNS0Fzwmu6jWSrInAhMj9BxjCuMccVEdYiOqJB1epMZEouNjs4PmbfZ0scxc30_DZC1YGGIELPmPVtOvR6ytV67rvO9_hp8gg6s7iKcfsc5erldPN_c549Pdw8314-5KTEfc0t0y2ttG2pwi1uLgVZGcqopJRXosgWwHEyDGZdaYCx1zWhJqSC2KZkVbI4ut77rqemhNTCMQXdqHVyvw7vy2qm_lcEt1avfqDL5CMmTwfm3QfBvE8RR9S4a6Do9gJ-ioukqJa1YLf-VEsk5K5kkVZJWW6kJPiYK9mcjgtUnILVSO0DqE5AiRCVAqfHs939-2nZEkuBqK4B01Y2DoKJxMBhoXQAzqta7_2Z8AM4IprU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1844353816</pqid></control><display><type>article</type><title>Evasion of host immune defenses by human papillomavirus</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Westrich, Joseph A. ; Warren, Cody J. ; Pyeon, Dohun</creator><creatorcontrib>Westrich, Joseph A. ; Warren, Cody J. ; Pyeon, Dohun</creatorcontrib><description>•HPV dysregulates various molecular and cellular pathways to evade host defenses.•HPV alters transcription of key immune modulators.•HPV E6 and E7 interacts with core proteins of the interferon pathway.•HPV E5 and E7 downregulate surface expression of MHC molecules.•Papillomavirus genome evolution may be driven by virus evasion of host restriction. A majority of human papillomavirus (HPV) infections are asymptomatic and self-resolving in the absence of medical interventions. Various innate and adaptive immune responses, as well as physical barriers, have been implicated in controlling early HPV infections. However, if HPV overcomes these host immune defenses and establishes persistence in basal keratinocytes, it becomes very difficult for the host to eliminate the infection. The HPV oncoproteins E5, E6, and E7 are important in regulating host immune responses. These oncoproteins dysregulate gene expression, protein–protein interactions, posttranslational modifications, and cellular trafficking of critical host immune modulators. In addition to the HPV oncoproteins, sequence variation and dinucleotide depletion in papillomavirus genomes has been suggested as an alternative strategy for evasion of host immune defenses. Since anti-HPV host immune responses are also considered to be important for antitumor immunity, immune dysregulation by HPV during virus persistence may contribute to immune suppression essential for HPV-associated cancer progression. Here, we discuss cellular pathways dysregulated by HPV that allow the virus to evade various host immune defenses.</description><identifier>ISSN: 0168-1702</identifier><identifier>EISSN: 1872-7492</identifier><identifier>DOI: 10.1016/j.virusres.2016.11.023</identifier><identifier>PMID: 27890631</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Adaptive Immunity ; APOBEC Deaminases ; APOBEC3 ; Cytidine Deaminase ; Cytosine Deaminase - genetics ; Cytosine Deaminase - immunology ; disease course ; DNA Methylation ; gene expression ; Gene Expression Regulation ; genome ; Genome, Viral ; Histone modification ; Histones - genetics ; Histones - immunology ; HPV ; Humans ; Immune Evasion ; immune response ; Immunity, Innate ; immunomodulators ; Innate immunity ; keratinocytes ; Keratinocytes - immunology ; Keratinocytes - virology ; medical treatment ; neoplasms ; NF-kappa B - genetics ; NF-kappa B - immunology ; Oncogene ; oncogene proteins ; Oncogene Proteins, Viral - genetics ; Oncogene Proteins, Viral - immunology ; Papillomaviridae ; Papillomaviridae - genetics ; Papillomaviridae - growth &amp; development ; Papillomaviridae - pathogenicity ; Papillomavirus ; Papillomavirus Infections - genetics ; Papillomavirus Infections - immunology ; Papillomavirus Infections - pathology ; Papillomavirus Infections - virology ; post-translational modification ; protein-protein interactions ; Restriction factor ; sequence diversity ; Tumor virus ; Virion - genetics ; Virion - growth &amp; development ; Virion - pathogenicity ; Virus evolution ; Virus Replication ; viruses</subject><ispartof>Virus research, 2017-03, Vol.231, p.21-33</ispartof><rights>2016 The Authors</rights><rights>Copyright © 2016 The Authors. Published by Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c504t-f1ad49afb2c0d0df0e26c842a2216ea5deef4ecb0348a7008a93252271fb53f73</citedby><cites>FETCH-LOGICAL-c504t-f1ad49afb2c0d0df0e26c842a2216ea5deef4ecb0348a7008a93252271fb53f73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0168170216305627$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27890631$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Westrich, Joseph A.</creatorcontrib><creatorcontrib>Warren, Cody J.</creatorcontrib><creatorcontrib>Pyeon, Dohun</creatorcontrib><title>Evasion of host immune defenses by human papillomavirus</title><title>Virus research</title><addtitle>Virus Res</addtitle><description>•HPV dysregulates various molecular and cellular pathways to evade host defenses.•HPV alters transcription of key immune modulators.•HPV E6 and E7 interacts with core proteins of the interferon pathway.•HPV E5 and E7 downregulate surface expression of MHC molecules.•Papillomavirus genome evolution may be driven by virus evasion of host restriction. A majority of human papillomavirus (HPV) infections are asymptomatic and self-resolving in the absence of medical interventions. Various innate and adaptive immune responses, as well as physical barriers, have been implicated in controlling early HPV infections. However, if HPV overcomes these host immune defenses and establishes persistence in basal keratinocytes, it becomes very difficult for the host to eliminate the infection. The HPV oncoproteins E5, E6, and E7 are important in regulating host immune responses. These oncoproteins dysregulate gene expression, protein–protein interactions, posttranslational modifications, and cellular trafficking of critical host immune modulators. In addition to the HPV oncoproteins, sequence variation and dinucleotide depletion in papillomavirus genomes has been suggested as an alternative strategy for evasion of host immune defenses. Since anti-HPV host immune responses are also considered to be important for antitumor immunity, immune dysregulation by HPV during virus persistence may contribute to immune suppression essential for HPV-associated cancer progression. Here, we discuss cellular pathways dysregulated by HPV that allow the virus to evade various host immune defenses.</description><subject>Adaptive Immunity</subject><subject>APOBEC Deaminases</subject><subject>APOBEC3</subject><subject>Cytidine Deaminase</subject><subject>Cytosine Deaminase - genetics</subject><subject>Cytosine Deaminase - immunology</subject><subject>disease course</subject><subject>DNA Methylation</subject><subject>gene expression</subject><subject>Gene Expression Regulation</subject><subject>genome</subject><subject>Genome, Viral</subject><subject>Histone modification</subject><subject>Histones - genetics</subject><subject>Histones - immunology</subject><subject>HPV</subject><subject>Humans</subject><subject>Immune Evasion</subject><subject>immune response</subject><subject>Immunity, Innate</subject><subject>immunomodulators</subject><subject>Innate immunity</subject><subject>keratinocytes</subject><subject>Keratinocytes - immunology</subject><subject>Keratinocytes - virology</subject><subject>medical treatment</subject><subject>neoplasms</subject><subject>NF-kappa B - genetics</subject><subject>NF-kappa B - immunology</subject><subject>Oncogene</subject><subject>oncogene proteins</subject><subject>Oncogene Proteins, Viral - genetics</subject><subject>Oncogene Proteins, Viral - immunology</subject><subject>Papillomaviridae</subject><subject>Papillomaviridae - genetics</subject><subject>Papillomaviridae - growth &amp; development</subject><subject>Papillomaviridae - pathogenicity</subject><subject>Papillomavirus</subject><subject>Papillomavirus Infections - genetics</subject><subject>Papillomavirus Infections - immunology</subject><subject>Papillomavirus Infections - pathology</subject><subject>Papillomavirus Infections - virology</subject><subject>post-translational modification</subject><subject>protein-protein interactions</subject><subject>Restriction factor</subject><subject>sequence diversity</subject><subject>Tumor virus</subject><subject>Virion - genetics</subject><subject>Virion - growth &amp; development</subject><subject>Virion - pathogenicity</subject><subject>Virus evolution</subject><subject>Virus Replication</subject><subject>viruses</subject><issn>0168-1702</issn><issn>1872-7492</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1PwzAMhiMEgjH4C6hHLi35apNeEAiNDwmJC5yjNHVYprYZSTuJf09gDMGJk2P59WvHD0JnBBcEk-piVWxcmGKAWNCUF4QUmLI9NCNS0Fzwmu6jWSrInAhMj9BxjCuMccVEdYiOqJB1epMZEouNjs4PmbfZ0scxc30_DZC1YGGIELPmPVtOvR6ytV67rvO9_hp8gg6s7iKcfsc5erldPN_c549Pdw8314-5KTEfc0t0y2ttG2pwi1uLgVZGcqopJRXosgWwHEyDGZdaYCx1zWhJqSC2KZkVbI4ut77rqemhNTCMQXdqHVyvw7vy2qm_lcEt1avfqDL5CMmTwfm3QfBvE8RR9S4a6Do9gJ-ioukqJa1YLf-VEsk5K5kkVZJWW6kJPiYK9mcjgtUnILVSO0DqE5AiRCVAqfHs939-2nZEkuBqK4B01Y2DoKJxMBhoXQAzqta7_2Z8AM4IprU</recordid><startdate>20170302</startdate><enddate>20170302</enddate><creator>Westrich, Joseph A.</creator><creator>Warren, Cody J.</creator><creator>Pyeon, Dohun</creator><general>Elsevier B.V</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7S9</scope><scope>L.6</scope><scope>5PM</scope></search><sort><creationdate>20170302</creationdate><title>Evasion of host immune defenses by human papillomavirus</title><author>Westrich, Joseph A. ; Warren, Cody J. ; Pyeon, Dohun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c504t-f1ad49afb2c0d0df0e26c842a2216ea5deef4ecb0348a7008a93252271fb53f73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adaptive Immunity</topic><topic>APOBEC Deaminases</topic><topic>APOBEC3</topic><topic>Cytidine Deaminase</topic><topic>Cytosine Deaminase - genetics</topic><topic>Cytosine Deaminase - immunology</topic><topic>disease course</topic><topic>DNA Methylation</topic><topic>gene expression</topic><topic>Gene Expression Regulation</topic><topic>genome</topic><topic>Genome, Viral</topic><topic>Histone modification</topic><topic>Histones - genetics</topic><topic>Histones - immunology</topic><topic>HPV</topic><topic>Humans</topic><topic>Immune Evasion</topic><topic>immune response</topic><topic>Immunity, Innate</topic><topic>immunomodulators</topic><topic>Innate immunity</topic><topic>keratinocytes</topic><topic>Keratinocytes - immunology</topic><topic>Keratinocytes - virology</topic><topic>medical treatment</topic><topic>neoplasms</topic><topic>NF-kappa B - genetics</topic><topic>NF-kappa B - immunology</topic><topic>Oncogene</topic><topic>oncogene proteins</topic><topic>Oncogene Proteins, Viral - genetics</topic><topic>Oncogene Proteins, Viral - immunology</topic><topic>Papillomaviridae</topic><topic>Papillomaviridae - genetics</topic><topic>Papillomaviridae - growth &amp; development</topic><topic>Papillomaviridae - pathogenicity</topic><topic>Papillomavirus</topic><topic>Papillomavirus Infections - genetics</topic><topic>Papillomavirus Infections - immunology</topic><topic>Papillomavirus Infections - pathology</topic><topic>Papillomavirus Infections - virology</topic><topic>post-translational modification</topic><topic>protein-protein interactions</topic><topic>Restriction factor</topic><topic>sequence diversity</topic><topic>Tumor virus</topic><topic>Virion - genetics</topic><topic>Virion - growth &amp; development</topic><topic>Virion - pathogenicity</topic><topic>Virus evolution</topic><topic>Virus Replication</topic><topic>viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Westrich, Joseph A.</creatorcontrib><creatorcontrib>Warren, Cody J.</creatorcontrib><creatorcontrib>Pyeon, Dohun</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>AGRICOLA</collection><collection>AGRICOLA - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Virus research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Westrich, Joseph A.</au><au>Warren, Cody J.</au><au>Pyeon, Dohun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evasion of host immune defenses by human papillomavirus</atitle><jtitle>Virus research</jtitle><addtitle>Virus Res</addtitle><date>2017-03-02</date><risdate>2017</risdate><volume>231</volume><spage>21</spage><epage>33</epage><pages>21-33</pages><issn>0168-1702</issn><eissn>1872-7492</eissn><abstract>•HPV dysregulates various molecular and cellular pathways to evade host defenses.•HPV alters transcription of key immune modulators.•HPV E6 and E7 interacts with core proteins of the interferon pathway.•HPV E5 and E7 downregulate surface expression of MHC molecules.•Papillomavirus genome evolution may be driven by virus evasion of host restriction. A majority of human papillomavirus (HPV) infections are asymptomatic and self-resolving in the absence of medical interventions. Various innate and adaptive immune responses, as well as physical barriers, have been implicated in controlling early HPV infections. However, if HPV overcomes these host immune defenses and establishes persistence in basal keratinocytes, it becomes very difficult for the host to eliminate the infection. The HPV oncoproteins E5, E6, and E7 are important in regulating host immune responses. These oncoproteins dysregulate gene expression, protein–protein interactions, posttranslational modifications, and cellular trafficking of critical host immune modulators. In addition to the HPV oncoproteins, sequence variation and dinucleotide depletion in papillomavirus genomes has been suggested as an alternative strategy for evasion of host immune defenses. Since anti-HPV host immune responses are also considered to be important for antitumor immunity, immune dysregulation by HPV during virus persistence may contribute to immune suppression essential for HPV-associated cancer progression. Here, we discuss cellular pathways dysregulated by HPV that allow the virus to evade various host immune defenses.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>27890631</pmid><doi>10.1016/j.virusres.2016.11.023</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0168-1702
ispartof Virus research, 2017-03, Vol.231, p.21-33
issn 0168-1702
1872-7492
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5325784
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adaptive Immunity
APOBEC Deaminases
APOBEC3
Cytidine Deaminase
Cytosine Deaminase - genetics
Cytosine Deaminase - immunology
disease course
DNA Methylation
gene expression
Gene Expression Regulation
genome
Genome, Viral
Histone modification
Histones - genetics
Histones - immunology
HPV
Humans
Immune Evasion
immune response
Immunity, Innate
immunomodulators
Innate immunity
keratinocytes
Keratinocytes - immunology
Keratinocytes - virology
medical treatment
neoplasms
NF-kappa B - genetics
NF-kappa B - immunology
Oncogene
oncogene proteins
Oncogene Proteins, Viral - genetics
Oncogene Proteins, Viral - immunology
Papillomaviridae
Papillomaviridae - genetics
Papillomaviridae - growth & development
Papillomaviridae - pathogenicity
Papillomavirus
Papillomavirus Infections - genetics
Papillomavirus Infections - immunology
Papillomavirus Infections - pathology
Papillomavirus Infections - virology
post-translational modification
protein-protein interactions
Restriction factor
sequence diversity
Tumor virus
Virion - genetics
Virion - growth & development
Virion - pathogenicity
Virus evolution
Virus Replication
viruses
title Evasion of host immune defenses by human papillomavirus
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T12%3A55%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evasion%20of%20host%20immune%20defenses%20by%20human%20papillomavirus&rft.jtitle=Virus%20research&rft.au=Westrich,%20Joseph%20A.&rft.date=2017-03-02&rft.volume=231&rft.spage=21&rft.epage=33&rft.pages=21-33&rft.issn=0168-1702&rft.eissn=1872-7492&rft_id=info:doi/10.1016/j.virusres.2016.11.023&rft_dat=%3Cproquest_pubme%3E1844353816%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1844353816&rft_id=info:pmid/27890631&rft_els_id=S0168170216305627&rfr_iscdi=true